About Rebecca Berger, M.D.

Rebecca Berger, M.D.

Rebecca is a 2016-2017 NEJM Editorial Fellow. She graduated from Columbia University College of Physicians and Surgeons in 2013 and completed residency in Internal Medicine at Massachusetts General Hospital in 2016. She currently works as an attending physician in the MGH Hospital Medicine Group. Her interests include quality improvement, patient safety, process improvement, and medical education.

All posts by Rebecca Berger, M.D.

In Coronary Artery Disease, Can Nurture Override Nature?

• December 14th, 2016

Mr. Locke, a 48-year-old man with prehypertension, comes to your office for a routine visit. He has a strong family history of coronary artery disease (CAD); his father and two brothers had myocardial infarctions in their 50s. His BMI is 31 kg/m2, he is a nonsmoker, but he does not exercise routinely. You suggest that… Read More…

Reduction in HIV Transmission with Dapivirine Vaginal Ring – Is it Enough?

• November 30th, 2016

While you are working for one month in a health center in South Africa, a 19-year-old woman comes to the clinic and asks for your advice: She is HIV-negative, and is unsure of her partner’s HIV status. Is there anything she can do to prevent her from acquiring HIV? Preexposure prophylaxis (PrEP) with oral tenofovir-emtricitabine is… Read More…

Breast Cancer Tumor Size, Mammography, and Screening Effectiveness

• October 12th, 2016

A good screening test is capable of identifying a precursor or early-stage disease in an asymptomatic patient and targets a disease for which early treatment is available to improve the patient’s ultimate outcome. Controversies about mammography screening guidelines for early detection of breast cancer include the appropriate age to start and stop screening, the frequency… Read More…

Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease

• September 26th, 2016

Mr. Patrick is a 59-year-old man admitted to the hospital with a non-ST elevation myocardial infarction (NSTEMI). You start him on an aspirin, P2Y12 inhibitor, statin, and heparin, and discuss the need for cardiac catheterization and possible stent placement. Mr. Patrick has heard that there are different types of stents available and wants to know… Read More…

Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes

• August 17th, 2016

A 32-year-old woman with type 1 diabetes mellitus presents to your office. She is 8 weeks pregnant. Her blood sugar has been well controlled on a standard insulin pump, but she understands that blood sugar can be more difficult to control during pregnancy.  You have previously discussed the importance of tight glucose control in pregnancy… Read More…

Randomized Trial of Thymectomy in Myasthenia Gravis

• August 10th, 2016

As a third-year medical student in my neurology clerkship, I went to the emergency room to evaluate Ms. B, who presented with eyelid weakness and fatigue. She was a 45-year-old woman who was diagnosed 2 years earlier with myasthenia gravis (MG). This was her third hospitalization for exacerbation of the disease. At the time of… Read More…

Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit

• July 6th, 2016

Ms. G is a 42-year-old woman admitted to your ICU with septic shock in the setting of a urinary tract infection.  She was started on a norepinephrine infusion in the emergency room. Her labs reveal a creatinine of 3.0 mg/dL, increased from a prior baseline of 0.6 mg/dL; pH is 7.3 and potassium is 4.9… Read More…